ZEN is known to alter the balance between ER, Wnt/β-catenin and TGF-β signaling in prostatic cancer cells as well as ovarian cells, these being linked with the pro-proliferative and cancerogenic effects of ZEN [31,32]. The gene discussed is TGFB1; the disease is prostate carcinoma.